DK125693D0 - - Google Patents

Info

Publication number
DK125693D0
DK125693D0 DK931256A DK125693A DK125693D0 DK 125693 D0 DK125693 D0 DK 125693D0 DK 931256 A DK931256 A DK 931256A DK 125693 A DK125693 A DK 125693A DK 125693 D0 DK125693 D0 DK 125693D0
Authority
DK
Denmark
Application number
DK931256A
Other languages
Danish (da)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK931256A priority Critical patent/DK125693D0/da
Publication of DK125693D0 publication Critical patent/DK125693D0/da
Priority to IL11150194A priority patent/IL111501A0/xx
Priority to PCT/DK1994/000414 priority patent/WO1995012407A1/en
Priority to AU80581/94A priority patent/AU8058194A/en
Priority to ZA948721A priority patent/ZA948721B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21068—Tissue plasminogen activator (3.4.21.68), i.e. tPA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK931256A 1993-11-05 1993-11-05 DK125693D0 (enrdf_load_html_response)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DK931256A DK125693D0 (enrdf_load_html_response) 1993-11-05 1993-11-05
IL11150194A IL111501A0 (en) 1993-11-05 1994-11-02 Pharmaceutical compositions comprising lys-plasminogen and tissue plasminogen activator (t-PA) for the treatment of coronary thrombosis
PCT/DK1994/000414 WO1995012407A1 (en) 1993-11-05 1994-11-03 A pharmaceutical composition for the treatment of coronary thrombosis
AU80581/94A AU8058194A (en) 1993-11-05 1994-11-03 A pharmaceutical composition for the treatment of coronary thrombosis
ZA948721A ZA948721B (en) 1993-11-05 1994-11-04 A method of treating coronary thrombosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK931256A DK125693D0 (enrdf_load_html_response) 1993-11-05 1993-11-05

Publications (1)

Publication Number Publication Date
DK125693D0 true DK125693D0 (enrdf_load_html_response) 1993-11-05

Family

ID=8102801

Family Applications (1)

Application Number Title Priority Date Filing Date
DK931256A DK125693D0 (enrdf_load_html_response) 1993-11-05 1993-11-05

Country Status (5)

Country Link
AU (1) AU8058194A (enrdf_load_html_response)
DK (1) DK125693D0 (enrdf_load_html_response)
IL (1) IL111501A0 (enrdf_load_html_response)
WO (1) WO1995012407A1 (enrdf_load_html_response)
ZA (1) ZA948721B (enrdf_load_html_response)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412131D0 (en) * 1994-06-17 1994-08-10 British Bio Technology Thrombolytic composition
CN106890320A (zh) * 2015-12-18 2017-06-27 深圳瑞健生命科学研究院有限公司 一种用于预防或治疗急性及慢性血栓的方法
CN108778320A (zh) * 2015-12-18 2018-11-09 泰伦基国际有限公司 一种预防和治疗心血管病的新方法
ES2968254T3 (es) 2015-12-18 2024-05-08 Talengen Int Ltd Plasminógeno para su uso en la prevención o el tratamiento de la trombosis aguda y la trombosis crónica
TWI642442B (zh) 2016-12-15 2018-12-01 深圳瑞健生命科學硏究院有限公司 纖溶酶原在製備降低胰高血糖素分泌的藥物上的用途
US11389515B2 (en) 2016-12-15 2022-07-19 Talengen International Limited Method for mitigating heart disease
WO2018108161A1 (zh) 2016-12-15 2018-06-21 深圳瑞健生命科学研究院有限公司 一种预防和治疗肥胖症的方法和药物
US20190328850A1 (en) 2016-12-15 2019-10-31 Talengen International Limited Method for preventing and treating lipid metabolism disorders and related diseases thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814604D0 (en) * 1988-06-20 1988-07-27 Wellcome Found Medicaments
WO1991015235A1 (en) * 1990-03-30 1991-10-17 Survival Technology, Inc. t-PA ENHANCER PROFILE

Also Published As

Publication number Publication date
ZA948721B (en) 1995-05-08
WO1995012407A1 (en) 1995-05-11
IL111501A0 (en) 1995-01-24
AU8058194A (en) 1995-05-23

Similar Documents

Publication Publication Date Title
FR09C0038I2 (enrdf_load_html_response)
EP0637889A3 (enrdf_load_html_response)
EP0637598A3 (enrdf_load_html_response)
FR2701905B1 (enrdf_load_html_response)
EP0721427A4 (enrdf_load_html_response)
DK0611885T3 (enrdf_load_html_response)
DK2193D0 (enrdf_load_html_response)
FR2700841B1 (enrdf_load_html_response)
DK0645781T3 (enrdf_load_html_response)
EP0707697A4 (enrdf_load_html_response)
FR2706741B1 (enrdf_load_html_response)
FR2706733B1 (enrdf_load_html_response)
ECSDI930121S (enrdf_load_html_response)
ECSDI930105S (enrdf_load_html_response)
ECSDI930145S (enrdf_load_html_response)
ECSDI930147S (enrdf_load_html_response)
ECSDI930159S (enrdf_load_html_response)
ECSDI930163S (enrdf_load_html_response)
ECSDI930176S (enrdf_load_html_response)
ECSDI930177S (enrdf_load_html_response)
DK14293D0 (enrdf_load_html_response)
DK46993D0 (enrdf_load_html_response)
DK52193D0 (enrdf_load_html_response)
DK67893D0 (enrdf_load_html_response)
ECSDI930115S (enrdf_load_html_response)

Legal Events

Date Code Title Description
A0 Application filed
ATS Application withdrawn